The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone treatment in healthy women. Although the FDA approved testosterone therapy for the treatment of disorders involving the testes, pituitary and hypothalamus, it hasn't been approved for treating age-associated declines in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the security of testosterone. The study involved roughly 800 elderly men with low testosterone and symptoms associated with this ailment, including http://tinyurl.com/zq3zb78 physical and sexual dysfunction. The research is expected to shed more light on the security of testosterone treatment since the men's heart health was carefully tracked.
The recent conflicting findings on testosterone therapy prompted his team to run a big systematic literature search for studies assessing the relationship between testosterone replacement therapy and cardiovascular events among men and Patel. An estimated 13 million men in the United States suffer from low testosterone, which occurs when the body fails to make enough hormones because of a problem with the testicles or pituitary gland. This describes clear aging, an individual's sudden weight gain and loss of energy.
No clear lower limit of testosterone was established; nevertheless 15 ng per dL (0.5 nmol per L) generally is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had markedly decreased sexual desire in all situations and absent or markedly reduced climaxes. As a result of studies such as this, supplemented with anecdotal evidence, many women have been started on testosterone treatment. Most women can expect to spend one third of their lives in the postmenopausal stage. Depression, anger, moodiness, insomnia, and lack of well-being are common criticisms of postmenopausal women.
Website URL: http://tinyurl.com/zq3zb78